Starcom wins 999 Pharmaceuticals

GUANGZHOU - Starcom has won the China planning and buying account for Shenzhen-based 999 Pharmaceuticals, after a two month long pitch against two other agencies.

by | 01/22/2008

999 Pharmaceuticals is mainly focused in the highly competitive Chinese traditional medicine market, and specialises in cold and cough remedies.

The estimated billings are in excess of US$41million.

Related Articles